0.1800
-0.0050
(-2.70%)
At close: 2:17:46 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
776.5170
135.9430
750.3780
3,204.6360
Operating Income
-776.5170
-135.9430
-750.3780
-3,204.6360
Net Non Operating Interest Income Expense
296.4830
241.4210
86.0380
-30.5300
Other Income Expense
--
-83.4700
-41.8660
--
Pretax Income
-3,256.0850
22.0080
-706.2060
-3,235.1660
Net Income Common Stockholders
-3,256.0850
22.0080
-706.2060
-3,235.1660
Diluted NI Available to Com Stockholders
-3,256.0850
22.0080
-706.2060
-3,235.1660
Basic EPS
-0.06
0.00
-0.01
-0.06
Diluted EPS
-0.06
0.00
-0.01
-0.06
Basic Average Shares
53,803.3550
53,753.3560
53,753.3560
53,753.3560
Diluted Average Shares
53,803.3550
53,753.3560
53,753.3560
53,753.3560
Total Expenses
776.5170
135.9430
750.3780
3,204.6360
Net Income from Continuing & Discontinued Operation
-3,256.0850
22.0080
-706.2060
-3,235.1660
Normalized Income
-3,256.3540
22.0080
-706.2060
-3,235.1660
Interest Income
369.8800
241.4210
86.0380
--
Interest Expense
--
--
20.1360
30.5300
Net Interest Income
296.4830
241.4210
86.0380
-30.5300
EBIT
-3,340.6390
-135.9430
-750.3780
-3,204.6360
EBITDA
-3,340.6390
-135.9430
-750.3780
-2,908.8280
Reconciled Depreciation
--
--
364.5520
295.8080
Net Income from Continuing Operation Net Minority Interest
-3,256.0850
22.0080
-706.2060
-3,235.1660
Total Unusual Items Excluding Goodwill
0.2690
--
--
--
Total Unusual Items
0.2690
--
--
--
Normalized EBITDA
-3,340.9080
-135.9430
-750.3780
-2,908.8280
Tax Rate for Calcs
--
0.0004
--
--
12/31/2021 - 2/9/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SVA.TO Sernova Biotherapeutics Inc
0.2000
+8.11%
EPRX.TO Eupraxia Pharmaceuticals Inc.
4.5600
+2.70%
COV.V Covalon Technologies Ltd.
2.3000
-4.17%
MDNAF Medicenna Therapeutics Corp.
0.8200
+12.33%
ARMP Armata Pharmaceuticals, Inc.
1.2300
+4.24%
EDSA Edesa Biotech, Inc.
2.2601
-0.44%
TH.TO Theratechnologies Inc.
3.4800
-2.79%
YMAB Y-mAbs Therapeutics, Inc.
4.6900
+3.30%
SPRO Spero Therapeutics, Inc.
0.7542
+1.92%
LPCN Lipocine Inc.
3.0000
0.00%